πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 144 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10675283

Compositions and methods for white to beige adipogenesis

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10668087

Methods for inhibiting muscle atrophy

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10626399

Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10576091

Tomatidine, analogs thereof, compositions comprising same, and uses for same

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10555961

Materials and methods for treating bacterial infections using C-1 gentamicin

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10548860

HIF-1 modulator paint formulation and uses thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537577

Compounds and compositions for ossification and methods related thereto

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10531654

Methods and compositions for vein harvest and autografting

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10525101

Methods of treating inflammatory or autoimmune disorders with compounds that bind macropha

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513494

Methods, compounds, and compositions for anesthesia

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10487076

Compositions and methods for treating diseases and conditions

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10478435

Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10456404

Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney diseas

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10450371

Monoclonal antibody and antigens for diagnosing and treating lung disease and injury

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10434188

Hyaluronic acid binding domain-growth factor fusion protein cDNAs and fusion proteins for

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10307423

FBXO3 inhibitors

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10286054

Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for Clostridium diffici

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9962379

Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9506922

Methods for producing an immune response to tuberculosis

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9295754

Noggin inhibitory compositions for ossification and methods related thereto

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9155801

Amino acid sequences which enhance peptide conjugate solubility

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685404

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7741113

Cell-specific molecule and method for importing DNA into osteoblast nuclei

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted